麦科医药-B（02335）盘中涨超30%，截至发稿，股价稍回落上涨17.94%，现报19.26港元，成交额1.70亿港元。
11月4日晚间，麦科医药-B公告称，本公司与首都医科大学附属北京天坛医院（北京天坛医院）联合承担“重大新药创制”国家科技重大专项下涉及本公司关键产品MT200605的研究课题，且近期已收到本课题首笔中央财政专项经费。
按课题任务书及双方合作协议约定，本集团负责MT200605的研发、生产及临床试验供应。于MT200605II期临床试验完成后，本公司已收到本课题首笔中央财政专项经费，并正推动MT200605的临床开发迈向III期。本公司近期已取得MT200605用于治疗急性缺血性卒中患者的III期临床试验（III期临床试验）组长单位（北京天坛医院）伦理委员会的批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.